Developer docs
API playgroundTry for free, no card

Search company profiles

Orreco

Full company profile

uuid0000ps9

Namestring
Orreco
Legal namestring
Orreco Limited
Websiteurl
orreco.ai
Company typeenum
Private
Founded yearint
2010
Descriptiontext

Orreco (legal entity Orreco Limited, incorporated in Ireland) is a sports science intelligence platform founded in 2010 by Dr Brian Moore and Dr Andrew Hodgson in Galway, Ireland. The company sells a modular AI-driven performance stack — anchored by the Te@m web platform, the @thlete mobile app (v2.0 with Gen AI launched August 2024) and the FitrWoman/FitrCoach women's performance sub-brands — to elite professional sports teams (NBA, NFL, MLB, NHL, EPL, F1, PGA Tour), Olympic federations (USWNT, English Women's national team, Swiss FA, FAI, USA Swimming, The FA) and marquee endurance organisations (INEOS Britannia, Club Brugge, Ettifaq Club, Newcastle United). Modules include Biomarkers (point-of-care and venous testing), Motion Signal (computer-vision movement analysis), Medical Notes, Recovery Lab, Analytics & Reporting (B.A.R.I.), Wellness, Travel, Tr@ce (return-to-performance) and Tr*AI*n (training-load prediction), with deployments spanning 145+ countries.

The platform is built on a proprietary Bayesian inference engine embedded in an agentic AI architecture, with adaptive personalised reference ranges for each athlete and multimodal ingestion of biomarkers, GPS/external load, neuromuscular function, sleep/autonomic data, video, medical imaging, and free-text notes. Orreco claims an 85% sensitivity / 86% specificity non-contact soft-tissue injury risk model and a 400+ peer-reviewed publication base, supported by 19 PhDs on staff across haematology, biomarker science, computational intelligence, biostatistics and exercise immunology. Recent acquisitions (DDSA in December 2025 for computer vision, Jennis in January 2026 for hormone-intelligent IP) deepen both the AI stack and the women's performance franchise.

The business model combines enterprise SaaS subscriptions to the Te@m platform (quote-based, sales-led via a persistent 'Book Demo' CTA), on-site professional services for biomarker testing delivered by Orreco sports scientists, consumer app subscriptions via iOS App Store and Google Play for FitrWoman/FitrCoach, and licensing/royalty revenue (including an NBA SportRadar data licence). Distribution runs through direct enterprise sales augmented by accelerator/league partnership channels (Comcast NBCUniversal SportsTech, MLS Innovation Lab, LMA Technical Partner) and a UK/US footprint in London and Los Angeles. The company has raised approximately $12M+ across rounds since 2015, most recently a $4M Series A extension in December 2025 led by Mark Cuban with Enterprise Ireland participation.

Short descriptiontext

Orreco is an Irish sports science AI company that sells a modular Bayesian-inference platform — Te@m, @thlete, FitrWoman and computer-vision injury-risk tooling — to elite professional sports teams, Olympic federations, and women's performance programs across 145+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersGalway, Ireland
HQ citystring
Galway
HQ countrystring
Ireland
HQ regionstring
Europe
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
sports performance analytics, athlete biomarker monitoring, AI injury prediction, elite team decision support, female athlete science
Industry1 code
PRIMARYHSADAEAG
Performance Analysis & Video Coaching
NAICS code2 codes
  • Custom Computer Programming Services541511
  • Sporting and Athletic Goods Manufacturing33992
SIC code1 code
  • Sporting & Athletic Goods, Nec3949
Product category
Sports Performance Analytics Software
Social media profiles3 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Enterprise SaaS Subscriptions (Te@m Platform)
TypeSubscription Recurring
Description

Recurring subscription access to the modular Orreco Te@m platform (Biomarkers, Motion Signal, Medical Notes, Recovery Lab, Analytics & Reporting, Wellness, Travel, Tr@ce, Tr*AI*n) sold to elite professional sports teams and governing bodies. Licensing-style deployment to high-value elite customers (NBA, NFL, MLB, NHL, EPL, F1, PGA Tour).

orreco.ai
2Professional / Testing Services (Point-of-Care & Venous Biomarker Service)
TypeProfessional Services
Description

Delivery of biomarker testing services (capillary POC and venous lab analysis) performed on-site by Orreco sports scientists as part of broader client engagements, plus custom research and consulting engagements tied to the 300+ peer-reviewed publication base.

orreco.ai
3Consumer App Subscriptions (FitrWoman / FitrCoach)
TypeSubscription Recurring
Description

Direct-to-consumer subscriptions via App Store and Google Play for FitrWoman (female athlete menstrual cycle and performance tracking) and FitrCoach (coach platform).

orreco.ai
4Licensing / Data Rights (NBA SportRadar license)
TypeLicensing Royalties
Description

Per the company's 2024–2025 timeline, Orreco agreed an NBA SportRadar data license, indicating licensing/royalty-style revenue streams tied to league data rights.

orreco.ai
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Marketing or Sales, Operations
Pricing details2 tiers
1Quote-based enterprise pricing for the Te@m platform and modules (Biomarkers, Motion Signal, Medical Notes, Recovery Lab, B.A.R.I.) sold to elite teams.
ModelOther
Notes

Pricing not publicly disclosed; sales-led quote-based model via 'Book Demo'.

orreco.ai
2App-store pricing for individual FitrWoman consumer app (iOS/Android).
ModelSubscription
Notes

Consumer pricing controlled via Apple App Store and Google Play storefronts.

orreco.ai
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 6 records shown
1FitrWoman
Description

Female health app for athletes with menstrual cycle tracking and tailored training, nutrition and recovery advice.

orreco.ai
+5 more records
Core offering1 text field

Orreco provides a modular sports science intelligence platform for elite professional sports teams, federations, and athletes that combines biomarker analysis, computer-vision motion tracking, training-load monitoring, and women's cycle-aware performance science into a single AI-driven decision-support system. The Te@m platform is sold to elite teams with quote-based enterprise subscriptions, paired with the @thlete mobile app for athletes and the FitrWoman/FitrCoach sub-brands for female athletes; biomarker testing services (Point-of-Care and Venous) are delivered on-site as part of broader client engagements.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 85% accuracy in Premier League hamstring injury prediction model
+5 more records
Product overview1 text field

Orreco offers a unified, modular sports science intelligence platform for elite teams and athletes, built on a platform-plus-modules architecture and grounded in over 20 years of Olympic-level research. The Te@m Team Performance Platform is the central web-based product that unifies staff workflows, data and AI agents; it is paired with the @thlete mobile app (introduced 2022, upgraded to @thlete 2.0 with Gen AI in 2024) that gives athletes ownership of their own data, and the FitrWoman / FitrCoach sub-brands that provide women's cycle-aware performance support. Customers compose their stack from a library of modules — Biomarkers, Motion Signal, Recovery Lab, Medical Notes, Analytics & Reporting (B.A.R.I.), Women's Performance, Wellness, Travel, Tr@ce, Tr*AI*n and Push Content to Athletes — and back them with the Orreco.AI agentic AI layer that connects biomarker science, training load, medical data and match outputs into a single decision-support system. The portfolio has been expanded through the 2025 acquisition of Data Driven Sports Analytics (DDSA, adding computer vision) and the 2026 acquisition of Jennis (adding hormone-intelligent IP), and historically includes earlier platforms TrackOR (biomarker analytics, 2014) and ZONE (real-time internal load, 2016).

Product and service16 records
1Te@m Team Performance Platform
CategoryEnterprise performance intelligence platform
Description

Centralised modular performance ecosystem unifying internal load, external load, recovery, wellness, and medical data into a single connected dashboard for high-performance teams, powered by Bayesian agentic AI and the first platform to combine computer vision with internal and external load.

2@thlete Athlete App
CategoryAthlete mobile application
Description

Mobile athlete-facing companion app (@thlete 2.0 with Gen AI) giving athletes ownership of their performance, recovery, readiness and wellness data with a conversational interface for asking questions of their data.

3FitrWoman
CategoryFemale athlete consumer application
Description

The first menstrual tracking app for female athletes, backed by 20 years of Olympic-level research; helps athletes train, compete and recover in sync with their menstrual cycle via cycle tracking, hormonal insights and expert nutrition/recovery advice.

4FitrCoach
CategoryCoach platform for female athletes
Description

Coaching platform connecting coaches with female athletes to deliver cycle-informed training, nutrition and recovery programmes.

5Biomarkers Module
CategoryBiomarker analytics module
Description

Module providing objective blood biomarkers for real-time decision making, combining non-invasive Point of Care capillary testing (rapid daily readiness) with comprehensive venous lab testing (deep gold-standard analysis).

6Motion Signal
CategoryComputer-vision injury risk module
Description

Computer-vision movement technology that converts every movement into a live injury risk score, deviation analytics and tailored conditioning stimulus to flag non-contact soft-tissue injury risk.

7Recovery Lab
CategoryRecovery analytics module
Description

Decision-support module centralising biomarker results, GPS workload, neuromuscular function, wellness questionnaires, sleep and autonomic-nervous-system data to deliver a holistic personalised view of each athlete's recovery status.

8Medical Notes
CategoryMedical documentation module
Description

Centralised, searchable injury and illness documentation module supporting HEAP/SOAP notes, multimedia attachments (images, video, voice notes), injury/illness classification, status management and contextual biomarker/performance overlays.

9Analytics & Reporting (B.A.R.I.)
CategoryAnalytics and reporting module
Description

Dynamic dashboard and automated-reporting module unifying GPS, force, biomarkers and wellness data, automating daily/weekly/post-game reports and sending smart alerts when athletes cross critical thresholds.

10Orreco Agent (Orreco.AI)
CategoryAgentic AI decision layer
Description

AI platform connecting biomarker science, training load, medical data and match outputs into one intelligent agentic decision layer for elite sport, embedding proprietary Bayesian inference models.

11Jennis
CategoryWomen's health and performance platform
Description

Women's health and performance platform co-founded by Olympic champion Dame Jessica Ennis-Hill; brings hormone-intelligent IP integrated with Orreco's AI platform, FitrWoman and DDSA computer vision to create a unified women's performance ecosystem.

12Data Driven Sports Analytics (DDSA)
CategoryComputer vision analytics platform
Description

Melbourne-based computer vision startup providing visual movement analysis that feeds Motion Signal's AI-led performance platform, integrating GPS wearables, video-based movement analysis and biomarker testing to flag injury risk.

13Wellness Module
CategoryWellness questionnaire module
Description

Subjective questionnaire logs (muscle soreness, stress, fatigue, sleep, mood) with anatomical muscle selection, fed into Recovery Lab and reported via the athlete app.

14Women's Performance Module
CategoryWomen's performance module
Description

Module leveraging FitrWoman's menstrual cycle tracking, hormonal health monitoring and physiology-informed insights to individualise training, nutrition and recovery for female athletes.

15Travel Module
CategoryTravel load module
Description

Module identifying periods of high travel load across the season to contextualise physiological load and recovery decisions.

16@thlete 2.0 (Generative AI Athlete App)
CategoryGenerative AI athlete application
Description

Generative-AI upgrade of the @thlete app enabling conversational queries against athlete performance, biomarker, recovery and wellness data.

Scale indicator12 records

Each record includes

Type, Value, Description, Source

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Whoop is a consumer wearable focused on recovery, sleep and strain metrics that has been expanding into professional sports partnerships. It is an emerging peer in the recovery-monitoring layer that competes with Orreco's @thlete consumer app and Recovery Lab module.

2Biofourmis
TypeBroad incumbent
Description

Biofourmis is a broader digital health and biomarker analytics platform used in clinical and pharmaceutical settings. It is a broad incumbent in the underlying biomarker monitoring capability Orreco delivers for elite sport, though not focused on the pro-sports vertical.

TypeDirect peer
Description

Sparta Science applies force-plate and AI to predict injury risk and readiness for professional sports teams (NBA, NCAA, MLB). It overlaps directly with Orreco's Motion Signal and Recovery Lab injury-prediction capabilities.

TypeDirect peer
Description

STATSports provides GPS-based player tracking and load monitoring used by elite soccer, GAA and NFL teams. It competes directly with Orreco's external load and wearable integrations across similar elite team customers.

5Polar
TypeBroad incumbent
Description

Polar is a long-established heart rate and performance wearable brand with deep penetration in team sport. It is a broad incumbent in the underlying wearable layer that Orreco integrates with via GPS and the Recovery Lab ecosystem.

TypeDirect peer
Description

Kitman Labs is an athlete intelligence platform serving elite teams (NFL, NBA, EPL, rugby, soccer) with integrated medical, performance and injury analytics. It is a direct competitor to Orreco's Medical Notes, Recovery Lab and B.A.R.I. modules.

TypeEmerging player
Description

Oura Ring is a consumer wearable providing sleep, HRV and readiness data with growing adoption among elite athletes (Orreco itself integrates Oura in its Recovery Lab). It is an emerging peer in the longitudinal recovery/biomarker space that Orreco's consumer products compete with for athlete mindshare.

TypeDirect peer
Description

KinaTrax provides markerless computer-vision and 3D biomechanical analysis used in MLB and NCAA. It is a direct peer in the computer-vision motion-analysis layer that Orreco's Motion Signal (now augmented by DDSA) competes against.

TypeEmerging player
Description

InsideTracker is a biomarker analytics platform translating blood-test results into personalized performance and longevity recommendations. It is an emerging peer in the consumer-facing biomarker analytics space where Orreco's Biomarkers module and FitrCoach overlap, though it targets individuals rather than elite teams.

TypeDirect peer
Description

Catapult is the dominant GPS and athlete monitoring platform in elite pro sport (Soccer, NFL, NBA, EPL). It is the most directly comparable competitor to Orreco's Te@m platform, overlapping on load monitoring, injury risk and team analytics, though historically more focused on hardware-derived GPS than biomarker and computer vision.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers13 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration5 records

Each record includes

Title, Type, Description, Source

AI capability16 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles14 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors6 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Orreco

Sports Performance Analytics Softwareorreco.ai

Orreco is an Irish sports science AI company that sells a modular Bayesian-inference platform — Te@m, @thlete, FitrWoman and computer-vision injury-risk tooling — to elite professional sports teams, Olympic federations, and women's performance programs across 145+ countries.

What Orreco does

Orreco (legal entity Orreco Limited, incorporated in Ireland) is a sports science intelligence platform founded in 2010 by Dr Brian Moore and Dr Andrew Hodgson in Galway, Ireland. The company sells a modular AI-driven performance stack — anchored by the Te@m web platform, the @thlete mobile app (v2.0 with Gen AI launched August 2024) and the FitrWoman/FitrCoach women's performance sub-brands — to elite professional sports teams (NBA, NFL, MLB, NHL, EPL, F1, PGA Tour), Olympic federations (USWNT, English Women's national team, Swiss FA, FAI, USA Swimming, The FA) and marquee endurance organisations (INEOS Britannia, Club Brugge, Ettifaq Club, Newcastle United). Modules include Biomarkers (point-of-care and venous testing), Motion Signal (computer-vision movement analysis), Medical Notes, Recovery Lab, Analytics & Reporting (B.A.R.I.), Wellness, Travel, Tr@ce (return-to-performance) and Tr*AI*n (training-load prediction), with deployments spanning 145+ countries.

The platform is built on a proprietary Bayesian inference engine embedded in an agentic AI architecture, with adaptive personalised reference ranges for each athlete and multimodal ingestion of biomarkers, GPS/external load, neuromuscular function, sleep/autonomic data, video, medical imaging, and free-text notes. Orreco claims an 85% sensitivity / 86% specificity non-contact soft-tissue injury risk model and a 400+ peer-reviewed publication base, supported by 19 PhDs on staff across haematology, biomarker science, computational intelligence, biostatistics and exercise immunology. Recent acquisitions (DDSA in December 2025 for computer vision, Jennis in January 2026 for hormone-intelligent IP) deepen both the AI stack and the women's performance franchise.

The business model combines enterprise SaaS subscriptions to the Te@m platform (quote-based, sales-led via a persistent 'Book Demo' CTA), on-site professional services for biomarker testing delivered by Orreco sports scientists, consumer app subscriptions via iOS App Store and Google Play for FitrWoman/FitrCoach, and licensing/royalty revenue (including an NBA SportRadar data licence). Distribution runs through direct enterprise sales augmented by accelerator/league partnership channels (Comcast NBCUniversal SportsTech, MLS Innovation Lab, LMA Technical Partner) and a UK/US footprint in London and Los Angeles. The company has raised approximately $12M+ across rounds since 2015, most recently a $4M Series A extension in December 2025 led by Mark Cuban with Enterprise Ireland participation.

Orreco firmographics

Firmographics
Name
Orreco
Legal name
Orreco Limited
Website
https://orreco.ai
Company type
Private
Founded year
2010
Operating status
Operating
Headcount range
51–100 employees
Short description
Orreco is an Irish sports science AI company that sells a modular Bayesian-inference platform — Te@m, @thlete, FitrWoman and computer-vision injury-risk tooling — to elite professional sports teams, Olympic federations, and women's performance programs across 145+ countries.
Ownership category
akta.pro rank

Orreco industry classification

Industry
Product category
Sports Performance Analytics Software
NAICS
Custom Computer Programming Services (541511), Sporting and Athletic Goods Manufacturing (33992)
SIC
Sporting & Athletic Goods, Nec (3949)
akta.pro industry
PRIMARYHSADAEAG
Performance Analysis & Video Coaching

Keywords

  • Sports performance analytics
  • Athlete biomarker monitoring
  • AI injury prediction
  • Elite team decision support
  • Female athlete science

Where Orreco is headquartered

Location

Headquarters

HQ city
Galway
HQ country
Ireland
HQ region
Europe

Offices4 records

Markets served

Orreco business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

  1. Enterprise SaaS Subscriptions (Te@m Platform): Recurring subscription access to the modular Orreco Te@m platform (Biomarkers, Motion Signal, Medical Notes, Recovery Lab, Analytics & Reporting, Wellness, Travel, Tr@ce, Tr*AI*n) sold to elite professional sports teams and governing bodies. Licensing-style deployment to high-value elite customers (NBA, NFL, MLB, NHL, EPL, F1, PGA Tour).
  2. Professional / Testing Services (Point-of-Care & Venous Biomarker Service): Delivery of biomarker testing services (capillary POC and venous lab analysis) performed on-site by Orreco sports scientists as part of broader client engagements, plus custom research and consulting engagements tied to the 300+ peer-reviewed publication base.
  3. Consumer App Subscriptions (FitrWoman / FitrCoach): Direct-to-consumer subscriptions via App Store and Google Play for FitrWoman (female athlete menstrual cycle and performance tracking) and FitrCoach (coach platform).
  4. Licensing / Data Rights (NBA SportRadar license): Per the company's 2024–2025 timeline, Orreco agreed an NBA SportRadar data license, indicating licensing/royalty-style revenue streams tied to league data rights.

Pricing tiers

ModelBillingPrice
Other—Quote-based enterprise pricing for the Te@m platform and modules (Biomarkers, Motion Signal, Medical Notes, Recovery Lab, B.A.R.I.) sold to elite teams.
Subscription—App-store pricing for individual FitrWoman consumer app (iOS/Android).

Go-to-market motion3 records

Distribution channels5 records

Marketing channels8 records

Orreco product offering

Product offering

Core offering

Orreco provides a modular sports science intelligence platform for elite professional sports teams, federations, and athletes that combines biomarker analysis, computer-vision motion tracking, training-load monitoring, and women's cycle-aware performance science into a single AI-driven decision-support system. The Te@m platform is sold to elite teams with quote-based enterprise subscriptions, paired with the @thlete mobile app for athletes and the FitrWoman/FitrCoach sub-brands for female athletes; biomarker testing services (Point-of-Care and Venous) are delivered on-site as part of broader client engagements.

Product overview

Orreco offers a unified, modular sports science intelligence platform for elite teams and athletes, built on a platform-plus-modules architecture and grounded in over 20 years of Olympic-level research. The Te@m Team Performance Platform is the central web-based product that unifies staff workflows, data and AI agents; it is paired with the @thlete mobile app (introduced 2022, upgraded to @thlete 2.0 with Gen AI in 2024) that gives athletes ownership of their own data, and the FitrWoman / FitrCoach sub-brands that provide women's cycle-aware performance support. Customers compose their stack from a library of modules — Biomarkers, Motion Signal, Recovery Lab, Medical Notes, Analytics & Reporting (B.A.R.I.), Women's Performance, Wellness, Travel, Tr@ce, Tr*AI*n and Push Content to Athletes — and back them with the Orreco.AI agentic AI layer that connects biomarker science, training load, medical data and match outputs into a single decision-support system. The portfolio has been expanded through the 2025 acquisition of Data Driven Sports Analytics (DDSA, adding computer vision) and the 2026 acquisition of Jennis (adding hormone-intelligent IP), and historically includes earlier platforms TrackOR (biomarker analytics, 2014) and ZONE (real-time internal load, 2016).

Differentiator

Problem solved

Functional benefit

Brands

  • FitrWoman: Female health app for athletes with menstrual cycle tracking and tailored training, nutrition and recovery advice.
  • FitrCoach
  • @thlete
  • Te@m
  • Motion Signal
  • B.A.R.I.

Products and services

  • Te@m Team Performance Platform Centralised modular performance ecosystem unifying internal load, external load, recovery, wellness, and medical data into a single connected dashboard for high-performance teams, powered by Bayesian agentic AI and the first platform to combine computer vision with internal and external load.
  • @thlete Athlete App Mobile athlete-facing companion app (@thlete 2.0 with Gen AI) giving athletes ownership of their performance, recovery, readiness and wellness data with a conversational interface for asking questions of their data.
  • FitrWoman The first menstrual tracking app for female athletes, backed by 20 years of Olympic-level research; helps athletes train, compete and recover in sync with their menstrual cycle via cycle tracking, hormonal insights and expert nutrition/recovery advice.
  • FitrCoach Coaching platform connecting coaches with female athletes to deliver cycle-informed training, nutrition and recovery programmes.
  • Biomarkers Module Module providing objective blood biomarkers for real-time decision making, combining non-invasive Point of Care capillary testing (rapid daily readiness) with comprehensive venous lab testing (deep gold-standard analysis).
  • Motion Signal Computer-vision movement technology that converts every movement into a live injury risk score, deviation analytics and tailored conditioning stimulus to flag non-contact soft-tissue injury risk.
  • Recovery Lab Decision-support module centralising biomarker results, GPS workload, neuromuscular function, wellness questionnaires, sleep and autonomic-nervous-system data to deliver a holistic personalised view of each athlete's recovery status.
  • Medical Notes Centralised, searchable injury and illness documentation module supporting HEAP/SOAP notes, multimedia attachments (images, video, voice notes), injury/illness classification, status management and contextual biomarker/performance overlays.
  • Analytics & Reporting (B.A.R.I.) Dynamic dashboard and automated-reporting module unifying GPS, force, biomarkers and wellness data, automating daily/weekly/post-game reports and sending smart alerts when athletes cross critical thresholds.
  • Orreco Agent (Orreco.AI) AI platform connecting biomarker science, training load, medical data and match outputs into one intelligent agentic decision layer for elite sport, embedding proprietary Bayesian inference models.
  • Jennis Women's health and performance platform co-founded by Olympic champion Dame Jessica Ennis-Hill; brings hormone-intelligent IP integrated with Orreco's AI platform, FitrWoman and DDSA computer vision to create a unified women's performance ecosystem.
  • Data Driven Sports Analytics (DDSA) Melbourne-based computer vision startup providing visual movement analysis that feeds Motion Signal's AI-led performance platform, integrating GPS wearables, video-based movement analysis and biomarker testing to flag injury risk.
  • Wellness Module Subjective questionnaire logs (muscle soreness, stress, fatigue, sleep, mood) with anatomical muscle selection, fed into Recovery Lab and reported via the athlete app.
  • Women's Performance Module Module leveraging FitrWoman's menstrual cycle tracking, hormonal health monitoring and physiology-informed insights to individualise training, nutrition and recovery for female athletes.
  • Travel Module Module identifying periods of high travel load across the season to contextualise physiological load and recovery decisions.
  • @thlete 2.0 (Generative AI Athlete App) Generative-AI upgrade of the @thlete app enabling conversational queries against athlete performance, biomarker, recovery and wellness data.

Quantifiable outcome

  • 85% accuracy in Premier League hamstring injury prediction model
  • +5 more outcomes

Companies that use Orreco

Customer profile

Named customers13 records

Segments5 records

Ideal customer profiles3 records

Orreco technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability16 records

Feature7 records

Orreco partnerships and signals

Strategic signal

Scale indicators12 records

Recent moves8 records

Expansion highlights7 records

Orreco competitors and assessment

Company assessment

Emerging players

  • Whoop: Whoop is a consumer wearable focused on recovery, sleep and strain metrics that has been expanding into professional sports partnerships. It is an emerging peer in the recovery-monitoring layer that competes with Orreco's @thlete consumer app and Recovery Lab module.
  • Oura: Oura Ring is a consumer wearable providing sleep, HRV and readiness data with growing adoption among elite athletes (Orreco itself integrates Oura in its Recovery Lab). It is an emerging peer in the longitudinal recovery/biomarker space that Orreco's consumer products compete with for athlete mindshare.
  • InsideTracker: InsideTracker is a biomarker analytics platform translating blood-test results into personalized performance and longevity recommendations. It is an emerging peer in the consumer-facing biomarker analytics space where Orreco's Biomarkers module and FitrCoach overlap, though it targets individuals rather than elite teams.

Broad incumbents

  • Biofourmis: Biofourmis is a broader digital health and biomarker analytics platform used in clinical and pharmaceutical settings. It is a broad incumbent in the underlying biomarker monitoring capability Orreco delivers for elite sport, though not focused on the pro-sports vertical.
  • Polar: Polar is a long-established heart rate and performance wearable brand with deep penetration in team sport. It is a broad incumbent in the underlying wearable layer that Orreco integrates with via GPS and the Recovery Lab ecosystem.

Direct peers

  • Sparta Science: Sparta Science applies force-plate and AI to predict injury risk and readiness for professional sports teams (NBA, NCAA, MLB). It overlaps directly with Orreco's Motion Signal and Recovery Lab injury-prediction capabilities.
  • STATSports: STATSports provides GPS-based player tracking and load monitoring used by elite soccer, GAA and NFL teams. It competes directly with Orreco's external load and wearable integrations across similar elite team customers.
  • Kitman Labs: Kitman Labs is an athlete intelligence platform serving elite teams (NFL, NBA, EPL, rugby, soccer) with integrated medical, performance and injury analytics. It is a direct competitor to Orreco's Medical Notes, Recovery Lab and B.A.R.I. modules.
  • KinaTrax: KinaTrax provides markerless computer-vision and 3D biomechanical analysis used in MLB and NCAA. It is a direct peer in the computer-vision motion-analysis layer that Orreco's Motion Signal (now augmented by DDSA) competes against.
  • Catapult Sports: Catapult is the dominant GPS and athlete monitoring platform in elite pro sport (Soccer, NFL, NBA, EPL). It is the most directly comparable competitor to Orreco's Te@m platform, overlapping on load monitoring, injury risk and team analytics, though historically more focused on hardware-derived GPS than biomarker and computer vision.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Orreco social profiles

Digital presence

Orreco compliance and trust

Trust signal

Compliance2 records

Orreco financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Orreco leadership team

Management profile

Number of profiles

Profiles14 records

Orreco subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Orreco funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Orreco M&A and investment

M&A and investment

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Orreco

What does Orreco do?

Orreco provides a modular sports science intelligence platform for elite professional sports teams, federations, and athletes that combines biomarker analysis, computer-vision motion tracking, training-load monitoring, and women's cycle-aware performance science into a single AI-driven decision-support system. The Te@m platform is sold to elite teams with quote-based enterprise subscriptions, paired with the @thlete mobile app for athletes and the FitrWoman/FitrCoach sub-brands for female athletes; biomarker testing services (Point-of-Care and Venous) are delivered on-site as part of broader client engagements.

Is Orreco a public or private company?

Orreco is a private company. It is classified as venture growth investor backed and is currently operating.

When was Orreco founded?

Orreco was founded in 2010. It employs 51 to 100 people.

Where is Orreco based?

Orreco is headquartered in Galway, Ireland, in the Europe region.

How does Orreco make money?

Four revenue lines are on record. Enterprise SaaS Subscriptions (Te@m Platform) is the primary driver. The others are professional / Testing Services (Point-of-Care & Venous Biomarker Service), consumer App Subscriptions (FitrWoman / FitrCoach) and licensing / Data Rights (NBA SportRadar license).

Who are Orreco's main competitors?

Emerging players on record are Whoop, Oura and InsideTracker. Broad incumbents are Biofourmis and Polar. Direct peers are Sparta Science, STATSports, Kitman Labs, KinaTrax and Catapult Sports.

Does Orreco have an API?

No public API is recorded for Orreco.

What industry is Orreco in?

Orreco's product category is Sports Performance Analytics Software. Its primary akta.pro industry code is HSADAEAG, Performance Analysis & Video Coaching. Its NAICS code is 541511 and its SIC code is 3949.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
SportforbusinessFuture Proofing Performance: Data is Only as Good as the Story it TellsA discussion at the Sport for Business Future Proofing Sport event in TU Dublin featured Irish women’s hockey captain Sarah Hawkshaw and Orreco co-founder Colin Morrissey exploring how data, biomarkers, AI, and wearable technology are transforming high-performance sport, while emphasizing the importance of keeping the athlete at the centre of technological innovation. The session highlighted that elite athletes now have access to extensive physiological monitoring including GPS, blood biomarkers, and AI-driven analysis, but the key skill lies in interpreting and communicating this information without creating mental overload for athletes. The discussion also raised concerns that many AI models in sport remain biased toward male physiology data, creating gaps in understanding female athlete performance that need to be addressed.Sports Business Journal10 Most Innovative Sports Tech Companies: Orreco blends biomarkers, motion and women’s performanceOrreco is an Irish sports technology company founded in 2010 that uses biomarkers, motion tracking, and artificial intelligence to monitor athlete performance and identify injury risk, serving clients across the NBA, NFL, MLB, NHL, Formula 1, PGA Tour, and Premier League. The company recently raised $4 million in funding from investor Mark Cuban and others while expanding its product portfolio through a series of acquisitions. Orreco also offers FitrWoman, a tool for monitoring hormonal cycles in female athletes, which has been adopted by the U.S. and English national women's soccer teams and USA Swimming.Silicon RepublicGalway’s Orreco signs up with MLS Innovation LabGalway-based athletic bio-analytics company Orreco has been selected to participate in the third edition of Major League Soccer's Innovation Lab, joining four other AI-focused companies in the cohort. Orreco uses AI, computer vision, and biomarker data to optimize athlete performance, predict injury risk, and accelerate recovery, and was chosen following a rigorous evaluation process that vetted hundreds of companies worldwide. The program will allow participants to test and scale their technologies in real-world MLS game environments, providing a pathway from innovation to implementation.TVTechnologyMLS Innovation Lab Selects AI PartnersMajor League Soccer has announced the 2026 cohort for its MLS Innovation Lab, now in its third year, which identifies and scales next-generation sports technology through real-world testing in MLS environments. Five AI-focused companies were selected—Springbok Analytics, Orreco, Fit:match, Advanced Image Robotics (AIR), and WMT AI Ticketing—to deploy solutions across player performance, fan engagement, and media production. The selected companies will test their technologies at MLS events including the 2026 MLS All-Star Game, MLS NEXT Fest, and Generation adidas Cup.PR NewswireMLS Innovation Lab Unveils Third Cohort Driving the Future of the GameMajor League Soccer announced the 2026 cohort of its MLS Innovation Lab, selecting five AI companies to test sports technology solutions in player performance, fan engagement, and media production. The selected companies—Springbok Analytics, Orreco, Fit:match.ai, Advanced Image Robotics, and WMT AI Ticketing—will deploy their technologies in real-world MLS environments including the 2026 MLS All-Star Game, Generation adidas Cup, and MLS NEXT Cup. The announcement arrives ahead of the 2026 FIFA World Cup, with MLS positioned to resume play during the tournament's closing week.Sports Business JournalMLS Innovation Lab selects 2026 cohortMLS selected five companies for its third Innovation Lab cohort, including Orreco, Springbok Analytics, Fit:match, AIR, and WMT Digital. The companies will trial AI technologies in athlete performance, fan experience, and ticketing, with MLS retaining equity options. The program includes two days in the league office next month.HomepageOrreco Acquires Jessica Ennis-Hill’s Jennis to Build Women’s Performance PlatformOrreco, an AI bio-analytics platform, has acquired Jennis, the hormone health and fitness platform founded by Olympic gold medalist Dame Jessica Ennis-Hill in 2021. The acquisition combines Jennis with Orreco's existing portfolio including FitrWoman and DDSA Computer Vision, creating what the company calls the "most advanced women's performance ecosystem" integrating hormonal health, menstrual cycle intelligence, biomechanics, and AI analytics. Orreco completed a $4 million Series A in 2024 led by Dallas Mavericks minority owner Mark Cuban, while Jennis had previously raised £1 million in pre-seed funding led by Maki.vc.BusinessCloudDame Jessica Ennis-Hill’s sports platform acquiredGalway-based SportTech company Orreco has acquired Jennis, the women’s health and performance platform co-founded by Olympic champion Dame Jessica Ennis-Hill, creating what it claims is the most advanced women’s performance ecosystem in the world. The deal integrates Jennis’ hormone-intelligent intellectual property with Orreco’s existing AI platform, FitrWoman product, and DDSA’s computer vision technology to provide comprehensive female performance analytics combining biological, biomechanical and hormonal data. The acquisition follows Orreco’s recent $4 million Series A extension featuring investor Mark Cuban and Enterprise Ireland, and builds on the company’s existing client base of more than 25 Olympic medallists and elite teams.Sports Business JournalSBJ Power Up: A deeper look at the USOPC Performance Innovation FundThe USOPC Performance Innovation Fund supports innovations such as AI-powered aerodynamics testing in speedskating, which led to a revolutionary technique called 'the American Push' that contributed to improved performance and world records. Orreco acquired Jennis, a women’s athlete app co-founded by Jessica Ennis-Hill, to integrate its content into its platform to benefit women athletes and extend its reach beyond elite sports.Business LiveMark Cuban-backed Orreco acquires Dame Jessica Ennis-Hill's JennisOrreco, an AI bio-analytics platform backed by Mark Cuban, has acquired Jennis, a women's hormone health and performance platform founded by Olympic gold medallist Dame Jessica Ennis-Hill. The acquisition combines Jennis's specialist training programs and wellness guidance with Orreco's existing portfolio including FitrWoman (used by England's Lionesses) and DDSA Computer Vision (used by Aryna Sabalenka), forming what the company claims will be the most advanced women's performance ecosystem in the world. The deal follows Orreco's recent $4 million Series A funding round led by Mark Cuban, the billionaire investor and minority owner of the Dallas Mavericks NBA team.